New semiconductor, robotics, and biotech centres to boost innovation and industry partnerships
Singapore is set to launch four key initiatives aimed at accelerating the commercialisation of research and development (R&D) in semiconductors, nucleic acid therapeutics, robotics, and medical technology. Announced by Second Minister for Trade and Industry Tan See Leng, these initiatives are part of the government’s broader strategy to strengthen innovation and industry collaboration.
S$180 million National Semiconductor Translation and Innovation Centre
Opening in April at Fusionopolis, this centre will focus on emerging technologies such as flat optics and silicon photonics. Companies and researchers will gain access to a “semiconductor manufacturing platform infrastructure,” including cleanroom facilities, advanced equipment, and expert scientists.
Dr. Tan highlighted the high costs associated with semiconductor manufacturing and noted that this initiative will provide businesses with access to essential infrastructure for prototyping and small-scale production. Additionally, it will support local talent development and facilitate technology transfer from A*Star and Singapore’s public universities.
S$97 million Nucleic Acid Therapeutics Initiative
This initiative will position Singapore as a regional hub for nucleic acid therapeutics (NAT) research and commercialisation. With a focus on ribonucleic acid (RNA) drugs and vaccines, it comprises two core components:
NAT Exchange: A platform for developing novel NAT formulations and technologies.
RNA Foundry: A facility dedicated to advancing RNA manufacturing processes.
Dr. Tan noted that Singapore has steadily built expertise in RNA research, and this initiative will help support local startups and SMEs while attracting global biotech firms.
S$38 million Medtech Catapult initiative
Launching in April, this programme will fast-track the development of medical technologies, including life-science tools and medical devices. It will provide support for companies to translate research into commercial products and upskill engineers.
Dr. Tan emphasized that Medtech Catapult will also help local contract manufacturers expand their capabilities beyond production into product design and development.
S$60 million for National Robotics Programme
The National Robotics Programme will receive new funding to enhance commercial applications in key industries, such as manufacturing, logistics, healthcare, and facilities management.
As part of this initiative, Singapore will establish RoboClusters, which are robotics innovation hubs that bring together public-sector researchers, industry leaders, and robotics firms to collaborate on sector-specific solutions.
Expected impact
The combined efforts of these four initiatives are projected to train over 200 specialised research talents, including engineers and scientists. Additionally, more than 75 R&D projects will be executed, and over 40 technologies will be licensed to industry players.
With these investments, Singapore aims to strengthen its position as a global innovation hub, fostering deeper partnerships between research institutions and businesses.
